YVONNE KUHN: Open Payments
NPI 1508099425 · MORAINE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 23 payments from 8 companies in 2025. Trend: 2023 $1,686 · 2024 $945 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $279 |
| Vanda Pharmaceuticals Inc. | 5 | $146 |
| Neurocrine BioSciences, Inc. | 4 | $101 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| Axsome Therapeutics, Inc. | 2 | $65 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: INVEGA SUSTENNA, INGREZZA, FANAPT, HETLIOZ, COBENFY, Auvelity, REXULTI, TRINTELLIX.
Industry payments across OH — which companies pay providers there.
